Has Anuj Suri, MD received payments from drug or device companies?

Yes. Drug and device makers reported $249,685 in general payments to Anuj Suri, MD across 363 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anuj Suri, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anuj Suri, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anuj Suri, MD

Gynecologic Oncology · Houston, TXNPI 1326366691

Payments from drug & device makers

$249,685in general payments, 2019–2025

Across 363 payments — averaging $687.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$124K
Tesaro, Inc.$54K
Pacira Pharmaceuticals Incorporated$48K
Intuitive Surgical$13K
Baxter Healthcare$5K
Johnson & Johnson$2K
plus $4K from 37 others

What the payments were for

Consulting fees$13,94019%
Speaking & faculty fees$27,54438%
Travel & lodging$10,33514%
Food & beverage$8,40012%
Education$12,26017%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	42	$124,068
Tesaro, Inc.	5	$53,615
Pacira Pharmaceuticals Incorporated	112	$48,130
Intuitive Surgical	9	$13,217
Baxter Healthcare	22	$4,809
Johnson & Johnson(2 entities)	5	$2,084
Merck	18	$423
Myriad Genetic Laboratories, Inc.	23	$375
Bayer	17	$368
Eisai Inc.	13	$277
Astellas Pharma US Inc	7	$251
Davol Inc.	3	$213
Dilon Technologies, Inc.	2	$196
Myovant Sciences Inc.	10	$177
AbbVie	9	$167
AstraZeneca(2 entities)	7	$138
Duchesnay USA Incorporated	1	$121
Daiichi Sankyo Inc.	5	$102
Therapeuticsmd, Inc.	7	$102
Mayne Pharma Commercial LLC	4	$81
Scynexis, Inc.	4	$77
Sumitomo Pharma America, Inc.	4	$77
Aspira Women's Health Inc	4	$68
Genmab U.S., Inc.	3	$60
Clovis Oncology, Inc.	3	$52
Organon	3	$51
Smith+Nephew	1	$49
Caris MPI, Inc.	2	$42
Baudax Bio Inc.	2	$39
Integra Lifesciences Corporation	2	$37
Medtronic	2	$27
Medical Device Business Services, Inc.	1	$24
Biom'up SA	1	$19
Sanara Medtech Inc.	1	$17
AMAG Pharmaceuticals, Inc.	1	$16
Hologic Sales And Service, LLC	1	$15
Millicent US Inc	1	$15
Evofem Biosciences, Inc.	1	$15
Coopersurgical, Inc.	1	$15
Meditrina	1	$15
KCI USA, Inc.	1	$14
Novo Nordisk	1	$13
Lupin Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$249,685 in reported general payments places this provider in the 85th percentile of 135 gynecologic oncology providers in Texas.

See all gynecologic oncology providers in Texas →

Medicare billing

Part B allowed, 2024

$60,576

Medicare patients

109

Services billed

281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Acetaminophen-CodeineAcetaminophen With Codeine	27	$72

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Houston

Pamela SolimanHouston$30.7M
Robert ColemanHouston$3.4M
Michael FrumovitzHouston$1M
Joseph LucciHouston$292K
David GershensonHouston$273K
Aparna KamatHouston$208K
Maurie MarkmanHouston$204K
Anil SoodHouston$187K
Larissa MeyerHouston$146K
Jan SundeHouston$107K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →